# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-24-000032
Filing Date
2024-05-08
Accepted
2024-05-08 16:07:27
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20240331.htm iXBRL | 10-Q | 1036633
2 | EX-31.1 | lgnd_33124exhibit311.htm | EX-31.1 | 15156
3 | EX-31.2 | lgnd_33124exhibit312.htm | EX-31.2 | 15426
4 | EX-32.1 | lgnd_33124exhibit321.htm | EX-32.1 | 11154
10 |  | lgnd-20240331_g1.jpg | GRAPHIC | 43732
| Complete submission text file | 0000886163-24-000032.txt |  | 7540771

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20240331.xsd | EX-101.SCH | 59341
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20240331_cal.xml | EX-101.CAL | 97273
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20240331_def.xml | EX-101.DEF | 349554
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20240331_lab.xml | EX-101.LAB | 763967
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20240331_pre.xml | EX-101.PRE | 532506
76 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20240331_htm.xml | XML | 987712

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 24925987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)